Analyst Expect Big Moves From Altimmune Inc (NASDAQ: ALT)

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]

Reassessing The Changing Outlook For Altimmune Inc (ALT)

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]

Altimmune Inc (NASDAQ: ALT) Is Getting Increasingly Hard To Ignore

With over 10.36 million Altimmune Inc (ALT) shares trading Friday and a closing price of $11.19 on the day, the dollar volume was approximately $115.9 million. The shares have shown a positive half year performance of 240.12% and its price on 01/05/24 lost nearly -4.28%. Currently, there are 53.73M common shares owned by the public […]

Uncovering Institutional Buying In Altimmune Inc (NASDAQ: ALT)

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]

Altimmune Inc (NASDAQ: ALT): The Best-Of-Breed For Investing?

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]

Altimmune Inc (NASDAQ: ALT): Stock That Needs Special Handling

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]

Is Altimmune Inc (NASDAQ: ALT) Back In The Buying Zone?

BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.53% valued currently at $8.29 million. In addition, The Vanguard Group, […]

Altimmune Inc (NASDAQ: ALT) Is Getting Increasingly Hard To Ignore

With over 52.73 million Altimmune Inc (ALT) shares trading Monday and a closing price of $4.63 on the day, the dollar volume was approximately $244.15 million. The shares have shown a positive half year performance of 8.43% and its price on 12/04/23 gained nearly 29.69%. Currently, there are 53.73M common shares owned by the public […]